Autoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosis

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Berg, Christoph P ^a   Blume, Karin ^a   Lauber, Kirsten ^a   Gregor, Michael ^a   Berg, Peter A ^a   Wesselborg, Sebastian ^a   Stein, Gerburg M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MUSCARINIC M3 RECEPTOR; RECEPTOR ANTIBODY; RECOMBINANT RECEPTOR; MUSCARINIC RECEPTOR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIMARY BILIARY CIRRHOSIS; STAGING; WESTERN BLOTTING; BILIARY CIRRHOSIS; BLOOD; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AUTOANTIBODIES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RECEPTORS, MUSCARINIC;

EID: 77957922330     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-120     Document Type: Article

References (50)

1. Gershwin ME, Rowley M, Davis PA, Leung P, Coppel R, Mackay IR. Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies. Prog Liver Dis 1992, 10:47-61.
2. Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 2004, 99:2147-2149. 10.1111/j.1572-0241.2004.41121.x, 15554995.
3. Mackay IR. Autoimmunity and primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000, 14:519-533. 10.1053/bega.2000.0101, 10976012.
4. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973, 289:674-678. 10.1056/NEJM197309272891306, 4580473.
5. Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?. J Hepatol 2004, 40:380-384. 10.1016/j.jhep.2003.11.033, 15123349.
6. Dohmen K, Shigematsu H, Miyamoto Y, Yamasaki F, Irie K, Ishibashi H. Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis. Dig Dis Sci 2002, 47:162-169. 10.1023/A:1013292210036, 11837719.
7. Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M, Galanos C, Huhn D. Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet 1989, 2:1419-1422. 10.1016/S0140-6736(89)92034-5, 2574361.
8. Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1989, 351:1620-1624.
9. Selmi C, Gershwin ME. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol 2004, 16:406-410. 10.1097/01.bor.0000130538.76808.c2, 15201604.
10. Xu L, Sakalian M, Shen Z, Loss G, Neuberger J, Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 2004, 39:151-156. 10.1002/hep.20024, 14752833.
11. Berg PA, Klein R. Immunology of primary biliary cirrhosis. Baillieres Clin Gastroenterol 1987, 1:675-706. 10.1016/0950-3528(87)90053-4, 3322437.
12. Drachman DB. How to recognize an antibody-mediated autoimmune disease: criteria. Res Publ Assoc Res Nerv Ment Dis 1990, 68:183-186.
13. Drachman DB. Autonomic "myasthenia": the case for an autoimmune pathogenesis. J Clin Invest 2003, 111:797-799. 153777, 12639983.
14. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993, 14:426-430. 10.1016/0167-5699(93)90244-F, 8216719.
15. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc 1957, 164:1439-1447.
16. Bjorkland A, Totterman TH. Is primary biliary cirrhosis an autoimmune disease?. Scand J Gastroenterol 1994, 204(Suppl):32-39.
17. Inamura K, Tsuji H, Nakamoto Y, Suzuki M, Kaneko S. Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis. Clin Exp Immunol 2006, 145:93-100. 10.1111/j.1365-2249.2006.03090.x, 1941992, 16792678.
18. Jones DE, Palmer JM, Kirby JA, De Cruz DJ, McCaughan GW, Sedgwick JD, Yeaman SJ, Burt AD, Bassendine MF. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver 2000, 20:351-356. 10.1034/j.1600-0676.2000.020005351.x, 11092252.
19. Zeniya M. Lessons from animal models of primary biliary cirrhosis. J Gastroenterol Hepatol 2000, 15:342-343. 10.1046/j.1440-1746.2000.02170.x, 10824874.
20. Feist E, Dorner T, Hansen A. [Indications and options of new immune modulatory therapies for Sjogren's syndrome]. Z Rheumatol 2007, 66:679-685. 10.1007/s00393-007-0231-z, 17999070.
21. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 2000, 157:1377-1391. 1850172, 11021840.
22. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004, 113:1419-1429. 406525, 15146239.
23. Lindstrom JM. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 2003, 998:41-52. 10.1196/annals.1254.007, 14592862.
24. Mang FW, Michieletti P, O'Rourke K, Cauch-Dudek K, Diamant N, Bookman A, Heathcote J. Primary biliary cirrhosis, sicca complex, and dysphagia. Dysphagia 1997, 12:167-170. 10.1007/PL00009532, 9190103.
25. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology 2001, 33:16-21. 10.1053/jhep.2001.21165, 11124815.
26. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol 1996, 104:454-459. 10.1046/j.1365-2249.1996.42748.x, 2200439, 9099930.
27. Gao J, Cha S, Jonsson R, Opalko J, Peck AB. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 2004, 50:2615-2621. 10.1002/art.20371, 15334476.
28. Alvaro D, Alpini G, Jezequel AM, Bassotti C, Francia C, Fraioli F, Romeo R, Marucci L, Le Sage G, Glaser SS, Benedetti A. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest 1997, 100:1349-1362. 10.1172/JCI119655, 508313, 9294100.
29. Cassiman D, Libbrecht L, Sinelli N, Desmet V, Denef C, Roskams T. The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am J Pathol 2002, 161:521-530. 1850744, 12163377.
30. Berg CP, Stein GM, Klein R, Pascu M, Berg T, Kammer W, Priemer M, Nordheim A, Schulze-Osthoff K, Gregor M, Wesselborg S, Berg PA. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients. Liver Int 2006, 26:846-855. 10.1111/j.1478-3231.2006.01303.x, 16911468.
31. Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome. Scand J Immunol 2004, 59:261-266. 10.1111/j.0300-9475.2004.01395.x, 15030576.
32. Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, Ito S, Tsutsumi A, Sumida T. Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren's syndrome. Ann Rheum Dis 2005, 64:510-511. 10.1136/ard.2004.025478, 1755406, 15708912.
33. Zigon P, Bozic B, Cucnik S, Rozman B, Tomsic M, Kveder T. Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjogren's syndrome?. Ann Rheum Dis 2005, 64:1247. author reply 1247, 1755593, 16014696.
34. Klein R, Huizenga JR, Gips CH, Berg PA. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol 1994, 20:181-189. 10.1016/S0168-8278(05)80056-X, 8006398.
35. Klein R, Pointner H, Zilly W, Glassner-Bittner B, Breuer N, Garbe W, Fintelmann V, Kalk JF, Müting D, Fischer R, Tittor W, Pausch J, Maier KP, Berg PA. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver 1997, 17:119-128.
36. Kovacs L, Marczinovits I, Gyorgy A, Toth GK, Dorgai L, Pal J, Molnar J, Pokorny G. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome. Rheumatology. Oxford 2005, 44:1021-1025. 10.1093/rheumatology/keh672, 15888503.
37. Reina S, Sterin-Borda L, Orman B, Borda E. Human mAChR antibodies from Sjogren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level. Clin Immunol 2004, 113:193-202. 10.1016/j.clim.2004.08.005, 15451477.
38. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Jänicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K, Wesselborg S. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000, 19:4563-4573. 10.1038/sj.onc.1203824, 11030145.
39. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002, 123:1144-1150. 10.1053/gast.2002.36057, 12360477.
40. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2000, 43:1647-1654. 10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P, 10902771.
41. Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, Peck AB, Humphreys-Beher MG. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice. Arthritis Rheum 2000, 43:2297-2306. 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X, 11037890.
42. Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, Peen E, Jonsson R, Humphreys-Beher MG. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc Natl Acad Sci USA 1998, 95:7538-7543. 10.1073/pnas.95.13.7538, 22675, 9636185.
43. Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?. Arthritis Rheum 2005, 52:2984-2995. 10.1002/art.21347, 16200578.
44. Schmidt M, Frings M, Mono ML, Guo Y, Oude Weernink PA, Evellin S, Han L, Jakobs KH. G Protein-coupled Receptor-induced Sensitization of Phospholipase C Stimulation by Receptor Tyrosine Kinases. J Biochem 2000, 275:32603-32610.
45. van Koppen CJ. Multiple pathways for the dynamin-regulated internalization of muscarinic acetylcholine receptors. Biochemical Society Transactions 2001, 29:505-508. 10.1042/BST0290505, 11498018.
46. Kyriatsoulis A, Manns M, Gerken G, Lohse AW, Maelicke A, Wessler I, Reske K, Meyer zum Büschenfelde KH. Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis. J Hepatol 1988, 6:283-290. 10.1016/S0168-8278(88)80044-8, 3292637.
47. Sundewall AC, Lefvert AK, Norberg R. Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodies. Clin Immunol Immunopathol 1987, 45:184-195. 10.1016/0090-1229(87)90033-X, 3665199.
48. Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, Sella S, Katz BP, Youinou P, Renaudineau Y, Larida B, Invernizzi P, Gershwin ME, Shoenfeld Y. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010, 34:55-58. 10.1016/j.jaut.2009.08.009, 19897339.
49. Berg CP, Thirumalai RK, Klein R, Gregor M, Baseman JB, Wesselborg S, Lauber K, Stein GM. Mycoplasma antigen as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int 2009, 29:797-809. 10.1111/j.1478-3231.2008.01942.x, 19638108.
50. Palmer JM, Doshi M, Kirby JA, Yeaman SJ, Bassendine MF, Jones DE. Secretory autoantibodies in primary biliary cirrhosis (PBC). Clin Exp Immunol 2000, 122:423-428. 10.1046/j.1365-2249.2000.01403.x, 1905785, 11122250.